<DrugInformationSummary id="CDR0000495426"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>Gemcitabine hydrochloride is a type of chemotherapy drug called an antimetabolite, which is a drug that mimics a natural chemical and prevents its use in cells. It disrupts DNA formation by mimicking a DNA building block. This slows or stops the growth of cancer cells and other rapidly growing cells. </DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/gemcitabinehydrochloride">Gemcitabine Hydrochloride</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000041213">gemcitabine hydrochloride</TerminologyLink><GlossaryLink ref="CDR0000508951">gemcitabine hydrochloride</GlossaryLink><USBrandNames><USBrandName>Gemzar</USBrandName><USBrandName>Infugem</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>jem-SY-tuh-been HY-droh-KLOR-ide</TermPronunciation><MediaLink ref="CDR0000718455" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000718454" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=GEMCITABINE+HYDROCHLORIDE&amp;pagesize=20&amp;page=2&amp;audience=consumer&amp;vfile=">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Gemcitabine Hydrochloride</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=GEMCITABINE+HYDROCHLORIDE&amp;pagesize=20&amp;page=2&amp;audience=consumer&amp;vfile=">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Gemcitabine hydrochloride is approved to be used alone or with other drugs to treat:</Para><ItemizedList Style="bullet" id="_6"><ListItem><Strong><GlossaryTermRef href="CDR0000444971" dictionary="Cancer.gov" audience="Patient">Breast cancer</GlossaryTermRef></Strong> that cannot be treated with or that did not respond to chemotherapy that included an <GlossaryTermRef href="CDR0000044916" dictionary="Cancer.gov" audience="Patient">anthracycline</GlossaryTermRef> drug. It is used  with <GlossaryTermRef href="CDR0000045258" dictionary="Cancer.gov" audience="Patient">paclitaxel</GlossaryTermRef> as the first therapy for cancer that has spread to other parts of the body.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000045323" dictionary="Cancer.gov" audience="Patient">Non-small cell lung cancer</GlossaryTermRef>.</Strong> It is used with <GlossaryTermRef href="CDR0000045230" dictionary="Cancer.gov" audience="Patient">cisplatin</GlossaryTermRef> in patients whose cancer is <GlossaryTermRef href="CDR0000045367" dictionary="Cancer.gov" audience="Patient">stage IIIA</GlossaryTermRef>, <GlossaryTermRef href="CDR0000682421" dictionary="Cancer.gov" audience="Patient">stage IIIB</GlossaryTermRef>, or <GlossaryTermRef href="CDR0000045144" dictionary="Cancer.gov" audience="Patient">stage IV</GlossaryTermRef>. </ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000445074" dictionary="Cancer.gov" audience="Patient">Ovarian cancer</GlossaryTermRef></Strong> that is advanced and has relapsed at least 6 months after treatment with <GlossaryTermRef href="CDR0000045841" dictionary="Cancer.gov" audience="Patient">platinum</GlossaryTermRef> chemotherapy. It is used with <GlossaryTermRef href="CDR0000045182" dictionary="Cancer.gov" audience="Patient">carboplatin</GlossaryTermRef>.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000044521" dictionary="Cancer.gov" audience="Patient">Pancreatic cancer</GlossaryTermRef>.</Strong> It is used alone in patients whose cancer is  <GlossaryTermRef href="CDR0000045490" dictionary="Cancer.gov" audience="Patient">stage II</GlossaryTermRef> or <GlossaryTermRef href="CDR0000045497" dictionary="Cancer.gov" audience="Patient">stage III</GlossaryTermRef> and cannot be removed by surgery or  <GlossaryTermRef href="CDR0000045511" dictionary="Cancer.gov" audience="Patient">stage IV</GlossaryTermRef>. It is used in patients whose cancer has been treated with <GlossaryTermRef href="CDR0000046090" dictionary="Cancer.gov" audience="Patient">fluorouracil</GlossaryTermRef>.</ListItem></ItemizedList><Para id="_3">Gemcitabine hydrochloride is also being studied in the treatment of other types of cancer.</Para>                          
 </Section><Section id="_About"><Title>More About Gemcitabine Hydrochloride</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/41213">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.15">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a696019.html">Gemcitabine Hydrochloride</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.16"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.17">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2022/bladder-cancer-chemo-effective-alternative-bcg">For Common Form of Bladder Cancer, Chemo Combo Effective Alternative to BCG</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C961">Find Clinical Trials for Gemcitabine Hydrochloride</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2006-10-05</DateFirstPublished><DateLastModified>2025-01-02</DateLastModified></DrugInformationSummary>
